IPG Photonics makes binding offer for Lumibird Medical for EUR 300 million
IPG Photonics Corporation
IPG Photonics Corporation IPGP | 0.00 |
- IPG Photonics entered a binding offer to acquire Lumibird Medical for EUR 300 million in cash on a cash-free, debt-free basis.
- Deal includes a contingent cash earnout of up to EUR 50 million tied to 2026 and 2027 performance metrics.
- Closing targeted for Q4 2026, subject to customary closing conditions.
- Lumibird Medical reported 2025 revenue of EUR 112.2 million, EBITDA of EUR 24.1 million, EBITDA margin of 21.5%.
- Transaction aims to expand IPG’s medical laser platform, combining ophthalmology and urology positions; expected to be accretive to margin, EBITDA, adjusted EPS.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IPG Photonics Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607161759PRIMZONEFULLFEED9763762) on July 16, 2026, and is solely responsible for the information contained therein.
